REFERENCES
- Hedley AA, Ogden CL, Johnson CL, Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002. JAMA. 2004;291(23):2847–2850.
- Dietz WH. Health consequences of obesity in youth: childhood predictors of adult disease. Pediatrics. 1998;101:518–525.
- Rodriguez MA, Winkleby MA, Ahn D, Identification of population subgroups of children and adolescents with high asthma prevalence: findings from the Third National Health and Nutrition Examination Survey. Arch Pediatr Adolesc Med. 2002;156(3):269–275.
- Mallory GB Jr, Fiser DH, Jackson R. Sleep-associated breathing disorders in morbidly obese children and adolescents. J Pediatr. 1989;115(6):892–897.
- Fagot-Campagna A, Narayan KM, Imperatore G. Type 2 diabetes in children. BMJ. 2001;322(7283):377–378.
- Taylor ED, Theim KR, Mirch MC, Orthopedic complications of overweight in children and adolescents. Pediatrics. 2006;117(6):2167–2174.
- Tait AR, Voepel-Lewis T, Burke C, Incidence and risk factors for perioperative adverse respiratory events in children who are obese. Anesthesiology. 2008;108(3):375–380.
- Nafiu OO, Reynolds PI, Bamgbade OA, Childhood body mass index and perioperative complications. Paediatr Anaesth. 2007;17(5):426–430.
- Rogers PC, Meacham LR, Oeffinger KC, Obesity in pediatric oncology. Pediatr Blood Cancer. 2005;45(7):881–891.
- Navarro WH. Impact of obesity in the setting of high dose chemotherapy. Bone Marrow Transplant. 2003;31(11):961–966.
- Wong M, Balleine RL, Blair EY, Predictors of vinorelbine pharmacokinetics and pharmacodynamics in patients with cancer. J Clin Oncol. 2006;24(16):2448–2455.
- Griggs JJ, Mangu PB, Anderson H, Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2012;30(99):1–10.
- Navarro WH, Loberiza FR Jr, Bajorunaite R, Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2006;12(5):541–551.
- Dickson TM, Kusnierz-Glaz CR, Blume KG, Impact of admission body weight and chemotherapy dose adjustment on the outcome of autologous bone marrow transplantation. Biol Blood Marrow Transplant. 1999;5(5):299–305.
- Tarella C, Caracciolo D, Gavarotti P, Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high dose chemotherapy and autograft. Bone Marrow Transplant. 2000;26(11):1185–1191.
- Meloni G, Proia A, Capria S, Obesity and autologous stem cell transplantation in acute myeloid leukemia. Bone Marrow Transplant. 2001;28(4):365–367.
- Fuji S, Kim SW, Yoshimura K, Possible association between obesity and posttransplantation complications including infectious diseases and acute graft-versus-host disease. Biol Blood Marrow Transplant. 2009;15(1):73–82.
- Bulley S, Gassas A, Dupuis LL, Inferior outcomes for overweight children undergoing allogeneic stem cell transplantation. Br J Haematol. 2008;140(2):214–217.
- Barker CC, Agovi MA, Logan B, Childhood obesity and outcomes after bone marrow transplantation for patients with severe aplastic anemia. Biol Blood Marrow Transplant. 2010;17(5):737–744.
- CDC Home. BMI percentile calculator for child and teen, metric version. http://apps.nccd.cdc.gov/ dnpabmi/Calculator.aspx?CalculatorType=Metric. Accessed May 12, 2012.
- Barlow, SE and the Expert Committee. Expert committee recommendations regarding the prevention, assessment and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007;120(Suppl 4);164–192.
- Group BMI Calculator, English, v1.1. Produced by CDC. www.cdc.gov/healthyweight/…/BMI_ group_calculator_English.xls. Accessed August 31, 2012.
- Thornley I, Lehmann LE, Sung L, et al. A multiagent strategy to decrease regimen-related toxicity in children undergoing allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2004;10:635–644.
- Matthes-Martin S, Potschger U, Bergmann K, Risk-adjusted outcome measurement in pediatric allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2008;14(3):335–343.
- National Cancer Institute. Common Terminology Criteria for Adverse Events v3.0. (NIH Publication No. 03-5410. Revised June 2003). National Cancer Institute, 2006.
- Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc. 1958;53:457–481.
- Cox DR. Regression models and life tables. J Roy Stat Soc, Series B. 1972;34:197–220.
- Deeg HJ, O'Donnell M, Tolar J, Optimization of conditioning for marrow transplantation from unrelated donors for patients with asplastic anemia after failure of immunosuppressive therapy. Blood. 2006;108(5):1485–1491.
- Cooke K. Acute lung injury after allogeneic stem cell transplantation: from the clinic, to the bench and back again. Pediatr Transplant. 2005;9(Suppl 7):25–36.
- Pepe MS, Mori M, Kaplan-M. Marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med. 1993;12(8):737–751.
- Hale, G. Autologous hematopoietic stem cell transplantation for pediatric solid tumors. Expert Rev Anticancer Ther. 2005;5(5):835–846.
- CIBMTR Annual Published Data. Summary Slides 2010. Courtesy of Vincent He. Slides 17-19 and 24-38. http://www.cibmtr.org/ReferenceCenter/SlidesReports/SummarySlides/pages/index.aspx. Accessed December 14, 2010.